Group One Trading
MRKR icon

Group One Trading’s Marker Therapeutics MRKR Stock Holding History

Group One Trading’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,850
Closed -$56K – 8437
2021
Q4 		$56K Sell
5,850
-8,510
-59% -$113K ﹤0.01% 6238
2021
Q3 		$243K Sell
14,360
-31,690
-69% -$649K ﹤0.01% 4969
2021
Q2 		$1.28M Buy
46,050
+2,340
+5% +$61.6K ﹤0.01% 3119
2021
Q1 		$979K Buy
43,710
+19,160
+78% +$438K ﹤0.01% 3261
2020
Q4 		$356K Buy
24,550
+6,270
+34% +$97.3K ﹤0.01% 3576
2020
Q3 		$274K Sell
18,280
-2,320
-11% -$42.3K ﹤0.01% 3395
2020
Q2 		$426K Buy
20,600
+12,920
+168% +$283K ﹤0.01% 2768
2020
Q1 		$146K Buy
7,680
+4,050
+112% +$103K ﹤0.01% 2994
2019
Q4 		$105K Buy
3,630
+910
+33% +$33.1K ﹤0.01% 3605
2019
Q3 		$139K Buy
2,720
+1,520
+127% +$89.8K ﹤0.01% 3348
2019
Q2 		$95K Buy
1,200
+160
+15% +$9.5K ﹤0.01% 3392
2019
Q1 		$69K Buy
1,040
+440
+73% +$25.7K ﹤0.01% 3405
2018
Q4 		$33K Buy
+600
New +$43.7K ﹤0.01% 3766

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's MRKR Position: Q1 2026 in Review

Group One Trading held its Marker Therapeutics (MRKR) position steady in Q1 2026 at 178 shares worth $231. The position accounts for ﹤0.01% of the portfolio, ranked #7387.

Group One Trading first reported a position in MRKR in Q2 2019 and has held it in 22 quarters since. The position peaked at $70K in Q3 2019. 35 funds tracked by Wall St. Rank hold MRKR as of Q1 2026.

  • Group One Trading held 178 shares of Marker Therapeutics worth $231 as of Q1 2026.
  • Group One Trading left its Marker Therapeutics share count unchanged in Q1 2026.
  • Marker Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7387 holding.
  • Group One Trading first reported a position in Marker Therapeutics in Q2 2019 and has held it in 22 quarters since.
  • Group One Trading's Marker Therapeutics position peaked at $70K in Q3 2019.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.